Chemotherapy-based regimens in multiple myeloma in 2020.
2020-01-01 Gentile, M; Morabito, F; Martino, M; Vigna, E; Martino, Ea; Mendicino, F; Martinelli, G; Cerchione, C.
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
2019-01-01 Frigeni, M; Besson, C; Visco, C; Fontaine, H; Goldaniga, M; Visentini, M; Pulsoni, A; Torres, Ha; Peveling-Oberhag, J; Rossotti, R; Zaja, F; Rigacci, L; Merli, M; Dorival, C; Alric, C; Piazza, F; Gentile, M; Ferrari, A; Pirisi, M; Nassi, L; Rattotti, S; Frustaci, A; Milella, M; Cencini, E; Defrancesco, I; Ferretti, Vv; Bruno, R; Hermine, O; Arcaini, L.
Unavailability of thymidine kinase does not preclude the use of german comprehensive prognostic index. results of an external validation analysis in early chonic lymphocytic leukemia and comparison with md anderson cancer center model.
2016-01-01 Molica, S; Giannarelli, D; Mirabelli, R; Levato, L; Russo, A; Linardi, M; Gentile, M; Morabito, F.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
2020-01-01 Raponi, S; Ilari, C; Della Starza, I; Cappelli, Lv; Cafforio, L; Piciocchi, A; Arena, V; Mariglia, P; Mauro, Fr; Gentile, M; Cutrona, G; Moia, R; Favini, C; Morabito, F; Rossi, D; Gaidano, G; Guarini, A; Del Giudice, I; Foà, R.
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.
2019-01-01 Martino, M; Rossi, M; Ferreri, A; Loteta, B; Morabito, A; Moscato, T; Console, G; Innao, V; Naso, V; Provenzano, Pf; Recchia, Ag; Gentile, M
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study
2017-01-01 Jurczyszyn, A; Gozzetti, A; Gdula-Argasińska, J; Czepiel, J; Vij, R; Fiala, M; Valls, Dj; Mądry, K; Waszczuk-Gajda, A; Grosicki, S; Barchnicka, A; Crusoe, E; Hungria, V; Gentile, M; Mele, G; Ksieniewicz, M; Vesole, Dh; Castillo, Jj.
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
2009-01-01 Gobbi, Pg; Valentino, F; Danova, M; Morabito, F; Rovati, B; Mammi, C; Gentile, M; Merli, F; Stelitano, C; Luminari, S; Quintana, G; Iannitto, E; Brugiatelli, M; Federico, M.
Bendamustine in multiple myeloma
2015-01-01 Gentile, M; Vigna, E; Recchia, Ag; Morabito, L; Mendicino, F; Giagnuolo, G; Morabito, F.
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
2020-01-01 Monti, P; Lionetti, M; De Luca, G; Menichini, P; Recchia, Ag; Matis, S; Colombo, M; Fabris, S; Speciale, A; Barbieri, M; Gentile, M; Zupo, S; Dono, M; Ibatici, A; Neri, A; Ferrarini, M; Fais, F; Fronza, G; Cutrona, G; Morabito, F.
Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia.
2015-01-01 Maura, F; Mosca, L; Fabris, S; Cutrona, G; Matis, S; Lionetti, M; Agnelli, L; Barbieri, M; D'Anca, M; Manzoni, M; Colombo, M; Massucco, C; Reverberi, D; Gentile, M; Recchia, Ag; Bossio, S; Ilariucci, F; Musolino, C; Di Raimondo, F; Cortelezzi, A; Morabito, F; Ferrarini, M; Neri, A.
Epigenetic regulation in myelodysplastic syndromes: implications for therapy
2011-01-01 Vigna, E; Recchia, Ag; Madeo, A; Gentile, M; Bossio, S; Mazzone, C; Lucia, E; Morabito, L; Gigliotti, V; Stefano, Ld; Caruso, N; Servillo, P; Franzese, S; Fimognari, F; Bisconte, Mg; Gentile, C; Morabito, F.
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience
2019-01-01 Innocenti, I; Morelli, F; Autore, F; Piciocchi, A; Frustaci, A; Mauro, Fr; Schiattone, L; Trentin, L; Del Poeta, G; Reda, G; Rigolin, Gm; Ibatici, A; Ciolli, S; Coscia, M; Sportoletti, P; Murru, R; Levato, L; Gentile, M; D'Arena, G; Efremov, Dg; Tedeschi, A; Scarfò, L; Cuneo, A; Foà, R; Laurenti, L.
Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
2011-01-01 Fabris, S; Scarciolla, O; Morabito, F; Cifarelli, Ra; Dininno, C; Cutrona, G; Matis, S; Recchia, Ag; Gentile, M; Ciceri, G; Ferrarini, M; Ciancio, A; Mannarella, C; Neri, A; Fragasso, A.
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia
2019-01-01 Reda, G; Cassin, R; Gentile, M; Mauro, Fr; Giannarelli, D; Fattizzo, B; Barbieri, M; Silvestris, I; Fabris, S; Morabito, F; Neri, A; Barcellini, W; Cortelezzi, A.
Venetoclax for the treatment of chronic lymphocytic leukemia.
2017-01-01 Gentile, M; Petrungaro, A; Uccello, G; Vigna, E; Recchia, Ag; Caruso, N; Bossio, S; De Stefano, L; Palummo, A; Storino, F; Martino, M; Morabito, F.
Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy.
2006-01-01 Callea, V; Brugiatelli, M; Stelitano, C; Gentile, M; Nobile, F; Morabito, F.
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.
2003-01-01 Guarini, A; Gaidano, G; Mauro, Fr; Capello, D; Mancini, F; De Propris, Ms; Mancini, M; Orsini, E; Gentile, M; Breccia, M; Cuneo, A; Castoldi, G; Foa, R.
CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)
2021-01-01 Gini, Guido; Di Rocco, Alice; Nassi, Luca; Arcari, Annalisa; Tisi, Maria Chiara; Loseto, Giacomo; Olivieri, Attilio; Gentile, Massimo; Annibali, Ombretta; Cabras, Maria Giuseppina; Chiappella, Annalisa; Rusconi, Chiara; Ferreri, Andrés José María; Balzarotti, Monica
Total body computed tomography scan in the initial work-up of binet stage a chronic lymphocytic leukemia patients: Results of the prospective, multicenter o-cll1-gisl study.
2013-01-01 Gentile, M; Cutrona, G; Fabris, S; Pesce, Ea; Baldini, L; Di Raimondo, F; Musolino, C; Di Tonno, P; Di Renzo, N; Molica, S; Brugiatelli, M; Ilariucci, F; Zupo, S; Matis, S; Maura, F; Vigna, E; Angrilli, F; Recchia, Ag; Quarta, G; Iannitto, E; Fragasso, A; Musto, P; Spriano, M; Vincelli, I; Vallisa, D; Cortelezzi, A; Mauro, Fr; Foà, R; Federico, M; Neri, A; Ferrarini, M; Morabito, F.
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia
2020-01-01 Condoluci, A; Terzi Di Bergamo, L; Langerbeins, P; Hoechstetter, Ma; Herling, Cd; De Paoli, L; Delgado, J; Rabe, Kg; Gentile, M; Doubek, M; Mauro, Fr; Chiodin, G; Mattsson, M; Bahlo, J; Cutrona, G; Kotaskova, J; Deambrogi, C; Ekström Smedby, K; Spina, V; Bruscaggin, A; W, Wu; Moia, R; Bianchi, E; Gerber, B; Zucca, E; Gillessen, S; Ghielmini, Me; Cavalli, F; Stuessi, G; Hess, Ma; Baumann, Ts; Neri, A; Ferrarini, M; Rosenquist, R; Forconi, F; Foa, R; Pospisilova, S; Morabito, F; Stilgenbauer, S; Döhner, H; Parikh, Sa; Wierda, Wg; Montserrat, E; Gaidano, G; Hallek, M; Rossi, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Chemotherapy-based regimens in multiple myeloma in 2020. | 1-gen-2020 | Gentile, M; Morabito, F; Martino, M; Vigna, E; Martino, Ea; Mendicino, F; Martinelli, G; Cerchione, C. | |
| Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection | 1-gen-2019 | Frigeni, M; Besson, C; Visco, C; Fontaine, H; Goldaniga, M; Visentini, M; Pulsoni, A; Torres, Ha; Peveling-Oberhag, J; Rossotti, R; Zaja, F; Rigacci, L; Merli, M; Dorival, C; Alric, C; Piazza, F; Gentile, M; Ferrari, A; Pirisi, M; Nassi, L; Rattotti, S; Frustaci, A; Milella, M; Cencini, E; Defrancesco, I; Ferretti, Vv; Bruno, R; Hermine, O; Arcaini, L. | |
| Unavailability of thymidine kinase does not preclude the use of german comprehensive prognostic index. results of an external validation analysis in early chonic lymphocytic leukemia and comparison with md anderson cancer center model. | 1-gen-2016 | Molica, S; Giannarelli, D; Mirabelli, R; Levato, L; Russo, A; Linardi, M; Gentile, M; Morabito, F. | |
| Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations | 1-gen-2020 | Raponi, S; Ilari, C; Della Starza, I; Cappelli, Lv; Cafforio, L; Piciocchi, A; Arena, V; Mariglia, P; Mauro, Fr; Gentile, M; Cutrona, G; Moia, R; Favini, C; Morabito, F; Rossi, D; Gaidano, G; Guarini, A; Del Giudice, I; Foà, R. | |
| Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials. | 1-gen-2019 | Martino, M; Rossi, M; Ferreri, A; Loteta, B; Morabito, A; Moscato, T; Console, G; Innao, V; Naso, V; Provenzano, Pf; Recchia, Ag; Gentile, M | |
| Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study | 1-gen-2017 | Jurczyszyn, A; Gozzetti, A; Gdula-Argasińska, J; Czepiel, J; Vij, R; Fiala, M; Valls, Dj; Mądry, K; Waszczuk-Gajda, A; Grosicki, S; Barchnicka, A; Crusoe, E; Hungria, V; Gentile, M; Mele, G; Ksieniewicz, M; Vesole, Dh; Castillo, Jj. | |
| Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma. | 1-gen-2009 | Gobbi, Pg; Valentino, F; Danova, M; Morabito, F; Rovati, B; Mammi, C; Gentile, M; Merli, F; Stelitano, C; Luminari, S; Quintana, G; Iannitto, E; Brugiatelli, M; Federico, M. | |
| Bendamustine in multiple myeloma | 1-gen-2015 | Gentile, M; Vigna, E; Recchia, Ag; Morabito, L; Mendicino, F; Giagnuolo, G; Morabito, F. | |
| Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients | 1-gen-2020 | Monti, P; Lionetti, M; De Luca, G; Menichini, P; Recchia, Ag; Matis, S; Colombo, M; Fabris, S; Speciale, A; Barbieri, M; Gentile, M; Zupo, S; Dono, M; Ibatici, A; Neri, A; Ferrarini, M; Fais, F; Fronza, G; Cutrona, G; Morabito, F. | |
| Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia. | 1-gen-2015 | Maura, F; Mosca, L; Fabris, S; Cutrona, G; Matis, S; Lionetti, M; Agnelli, L; Barbieri, M; D'Anca, M; Manzoni, M; Colombo, M; Massucco, C; Reverberi, D; Gentile, M; Recchia, Ag; Bossio, S; Ilariucci, F; Musolino, C; Di Raimondo, F; Cortelezzi, A; Morabito, F; Ferrarini, M; Neri, A. | |
| Epigenetic regulation in myelodysplastic syndromes: implications for therapy | 1-gen-2011 | Vigna, E; Recchia, Ag; Madeo, A; Gentile, M; Bossio, S; Mazzone, C; Lucia, E; Morabito, L; Gigliotti, V; Stefano, Ld; Caruso, N; Servillo, P; Franzese, S; Fimognari, F; Bisconte, Mg; Gentile, C; Morabito, F. | |
| Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience | 1-gen-2019 | Innocenti, I; Morelli, F; Autore, F; Piciocchi, A; Frustaci, A; Mauro, Fr; Schiattone, L; Trentin, L; Del Poeta, G; Reda, G; Rigolin, Gm; Ibatici, A; Ciolli, S; Coscia, M; Sportoletti, P; Murru, R; Levato, L; Gentile, M; D'Arena, G; Efremov, Dg; Tedeschi, A; Scarfò, L; Cuneo, A; Foà, R; Laurenti, L. | |
| Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study. | 1-gen-2011 | Fabris, S; Scarciolla, O; Morabito, F; Cifarelli, Ra; Dininno, C; Cutrona, G; Matis, S; Recchia, Ag; Gentile, M; Ciceri, G; Ferrarini, M; Ciancio, A; Mannarella, C; Neri, A; Fragasso, A. | |
| IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia | 1-gen-2019 | Reda, G; Cassin, R; Gentile, M; Mauro, Fr; Giannarelli, D; Fattizzo, B; Barbieri, M; Silvestris, I; Fabris, S; Morabito, F; Neri, A; Barcellini, W; Cortelezzi, A. | |
| Venetoclax for the treatment of chronic lymphocytic leukemia. | 1-gen-2017 | Gentile, M; Petrungaro, A; Uccello, G; Vigna, E; Recchia, Ag; Caruso, N; Bossio, S; De Stefano, L; Palummo, A; Storino, F; Martino, M; Morabito, F. | |
| Incidence of second neoplasia in patients with B-cell chronic lymphocytic leukemia treated with chlorambucil maintenance chemotherapy. | 1-gen-2006 | Callea, V; Brugiatelli, M; Stelitano, C; Gentile, M; Nobile, F; Morabito, F. | |
| Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. | 1-gen-2003 | Guarini, A; Gaidano, G; Mauro, Fr; Capello, D; Mancini, F; De Propris, Ms; Mancini, M; Orsini, E; Gentile, M; Breccia, M; Cuneo, A; Castoldi, G; Foa, R. | |
| CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL) | 1-gen-2021 | Gini, Guido; Di Rocco, Alice; Nassi, Luca; Arcari, Annalisa; Tisi, Maria Chiara; Loseto, Giacomo; Olivieri, Attilio; Gentile, Massimo; Annibali, Ombretta; Cabras, Maria Giuseppina; Chiappella, Annalisa; Rusconi, Chiara; Ferreri, Andrés José María; Balzarotti, Monica | |
| Total body computed tomography scan in the initial work-up of binet stage a chronic lymphocytic leukemia patients: Results of the prospective, multicenter o-cll1-gisl study. | 1-gen-2013 | Gentile, M; Cutrona, G; Fabris, S; Pesce, Ea; Baldini, L; Di Raimondo, F; Musolino, C; Di Tonno, P; Di Renzo, N; Molica, S; Brugiatelli, M; Ilariucci, F; Zupo, S; Matis, S; Maura, F; Vigna, E; Angrilli, F; Recchia, Ag; Quarta, G; Iannitto, E; Fragasso, A; Musto, P; Spriano, M; Vincelli, I; Vallisa, D; Cortelezzi, A; Mauro, Fr; Foà, R; Federico, M; Neri, A; Ferrarini, M; Morabito, F. | |
| International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia | 1-gen-2020 | Condoluci, A; Terzi Di Bergamo, L; Langerbeins, P; Hoechstetter, Ma; Herling, Cd; De Paoli, L; Delgado, J; Rabe, Kg; Gentile, M; Doubek, M; Mauro, Fr; Chiodin, G; Mattsson, M; Bahlo, J; Cutrona, G; Kotaskova, J; Deambrogi, C; Ekström Smedby, K; Spina, V; Bruscaggin, A; W, Wu; Moia, R; Bianchi, E; Gerber, B; Zucca, E; Gillessen, S; Ghielmini, Me; Cavalli, F; Stuessi, G; Hess, Ma; Baumann, Ts; Neri, A; Ferrarini, M; Rosenquist, R; Forconi, F; Foa, R; Pospisilova, S; Morabito, F; Stilgenbauer, S; Döhner, H; Parikh, Sa; Wierda, Wg; Montserrat, E; Gaidano, G; Hallek, M; Rossi, D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista40393
- 2 Contributo in Volume2
Data di pubblicazione
- In corso di stampa37
- 2020 - 202713195
- 2010 - 201915036
- 2000 - 20097892
- 1990 - 19993088
- 1980 - 19891038
- 1971 - 1979109
Editore
- Society for information display2
- TAYLOR & FRANCIS LTD, 4 PARK SQUA...2
- "Il pensiero scientifico" Editore1
- American Physical Society1
- Athens Institute for Education an...1
- Deputazione Storia Patria per la ...1
- Edizioni Scientifiche Calabresi1
- ELSEVIER SCIENCE BV, PO BOX 211, ...1
- ETS1
- Geological Society of America Spe...1
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS498
- PHYSICS LETTERS. SECTION B469
- THE EUROPEAN PHYSICAL JOURNAL. C,...397
- PHYSICAL REVIEW LETTERS272
- MOLECULES176
- PHYSICAL REVIEW D173
- BOLLETTINO FILOSOFICO168
- INTERNATIONAL JOURNAL OF MOLECULA...166
- APPLIED SCIENCES164
- FILOLOGIA ANTICA E MODERNA151
Serie
- ATINER'S CONFERENCE PAPER SERIES1
- INTERNATIONAL REVIEW OF NEUROBIOLOGY1
Keyword
- Humans268
- COVID-19164
- Italy154
- Calabria113
- Hadron-Hadron Scattering111
- Female110
- High Energy Physics - Experiment106
- Palladium105
- Hadron-Hadron scattering (experim...95
- Carbonylation88
Lingua
- eng28604
- ita6840
- fre287
- spa245
- ger96
- grc23
- alb18
- por16
- tur12
- lat10
Accesso al fulltext
- no fulltext39866
- open457
- reserved44
- restricted21
- internalNetwork5
- embargoed1
- partially open1